| International Standard Book Number |
9780063210820 electronic book
|
| International Standard Book Number |
9780063210790 hardcover
|
| International Standard Book Number |
0063210797 hardcover
|
| Dewey Decimal Classification Number |
615.3/72 23/eng/20220309
|
| Personal Name |
Bourla, Albert, author.
|
| Title Statement |
Moonshot : inside Pfizer's nine-month race to make the impossible possible / Dr. Albert Bourla.
|
| Varying Form of Title |
Inside Pfizer's nine-month race to make the impossible possible
|
| Varying Form of Title |
Inside Pfizer's 9-month race to make the impossible possible
|
| Edition Statement |
First edition.
|
| Production, Publication, Distribution, Manufacture, and Copyright Notice |
New York, NY : Harper Business, an imprint of HarperCollinsPublishers, [2022]
|
| Physical Description |
xix, 216 pages, 8 unnumbered pages of plates : illustrations (some color) ; 24 cm
|
| Content Type |
text txt rdacontent
|
| Media Type |
unmediated n rdamedia
|
| Carrier Type |
volume nc rdacarrier
|
| Bibliography, Etc. Note |
Includes bibliographical references (pages [197]-214).
|
| Formatted Contents Note |
Preface: Luck never comes to the unprepared -- Business NOT as usual -- What is obvious is not always right -- Thinking big makes the impossible possible -- Lightspeed -- The ultimate joy -- Past, present, future -- Manufacturing, the second miracle -- Equity : easier said than done -- Navigating a political minefield -- A beacon of hope -- The science of trust -- A pro-patient, pro-innovation agenda -- Epilogue -- Acknowledgments -- Appendix: Albert Bourla's "we stand with science" open letter to colleagues.
|
| Summary, Etc. |
"A riveting, fast-paced, inside look at one of the most incredible private sector achievements in history, Moonshot recounts the intensive nine months in 2020 when the scientists at Pfizer, under the visionary leadership of Dr. Albert Bourla, made "the impossible possible"--creating, testing, and manufacturing a safe and effective Covid-19 vaccine that previously would have taken years to develop." -- inside front book jacket flap.
|
| Summary, Etc. |
"The exclusive, first-hand, behind-the-scenes story of how Pfizer raced to create the first Covid-19 vaccine, told by Pfizer's CEO Dr. Albert Bourla"-- Provided by publisher.
|
| Subject-Personal Name |
Bourla, Albert.
|
| Subject |
Pfizer Inc.
|
| Subject |
Pfizer Inc. (OCoLC)fst00532911 fast
|
| Subject Added Entry - Topical Term |
Immunology.
|
| Subject Added Entry - Topical Term |
Immunology. (OCoLC)fst00968006 fast
|
| Subject Added Entry - Topical Term |
bioengineering. aat
|
| Subject Added Entry - Topical Term |
COVID-19 Pandemic, 2020-
|
| Subject Added Entry - Topical Term |
COVID-19 (Disease) sears
|
| Subject Added Entry - Topical Term |
Drug development History.
|
| Subject Added Entry - Topical Term |
COVID-19 (Disease) Vaccination.
|
| Subject Added Entry - Topical Term |
COVID-19 (Disease) Vaccination. (OCoLC)fst02021881 fast
|
| Subject Added Entry - Topical Term |
Viral vaccines Biotechnology.
|
| Subject Added Entry - Topical Term |
Viral vaccines.
|
| Subject Added Entry - Topical Term |
Viral vaccines. (OCoLC)fst01167621 fast
|
| Subject Added Entry - Topical Term |
Vaccines industry.
|
| Subject Added Entry - Topical Term |
Vaccines industry. (OCoLC)fst01163593 fast
|
| Subject Added Entry - Topical Term |
Biotechnology.
|
| Subject Added Entry - Topical Term |
Biotechnology. (OCoLC)fst00832729 fast
|
| Subject Added Entry - Topical Term |
COVID-19 (Disease) Prevention.
|
| Subject Added Entry - Topical Term |
COVID-19 (Disease) Prevention. (OCoLC)fst02021842 fast
|
| Subject Added Entry - Topical Term |
COVID-19 vaccines History.
|
| Subject Added Entry - Topical Term |
mRNA vaccines History.
|
| Subject Added Entry - Topical Term |
Viral Vaccines
|
| Subject Added Entry - Topical Term |
Allergy and Immunology
|
| Subject Added Entry - Topical Term |
Biotechnology
|
| Subject Added Entry - Topical Term |
Mâedicaments Dâeveloppement Histoire.
|
| Subject Added Entry - Topical Term |
COVID-19 Vaccination.
|
| Subject Added Entry - Topical Term |
Vaccins antiviraux Biotechnologie.
|
| Subject Added Entry - Topical Term |
Vaccins antiviraux.
|
| Subject Added Entry - Topical Term |
Vaccins Industrie.
|
| Subject Added Entry - Topical Term |
Immunologie.
|
| Subject Added Entry - Topical Term |
Biotechnologie.
|
| Subject Added Entry - Topical Term |
Pandâemie de COVID-19, 2020-
|
| Subject Added Entry - Topical Term |
BUSINESS & ECONOMICS / Industries / Pharmaceutical & Biotechnology. bisacsh
|
| Subject Added Entry - Topical Term |
MEDICAL / Immunology. bisacsh
|
| Subject Added Entry - Topical Term |
BUSINESS & ECONOMICS / Research & Development. bisacsh
|
| Subject Added Entry - Topical Term |
Drug development. (OCoLC)fst00898670 fast
|
| Subject Added Entry - Topical Term |
Viral vaccines Research. (OCoLC)fst01167622 fast
|
| Index Term-Genre/Form |
History. (OCoLC)fst01411628 fast
|
| Index Term-Genre/Form |
Informational works. lcgft
|
| Additional Physical Form Entry |
Online version: Bourla, Dr. Albert. New York : Harper Business, 2022 Moonshot (DLC) 2022001764 9780063210820
|